106 related articles for article (PubMed ID: 88732)
21. [Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
Pouillart P; Palangie T; Garcia-Giralt E; Jouve M; Bataini JP; Jaulerry M; Brugère J; Asselin B
Bull Cancer; 1980; 67(3):269-80. PubMed ID: 6157447
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
[No Abstract] [Full Text] [Related]
23. The role of chemotherapy in the treatment of lung cancer.
Selawry OS
Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
[No Abstract] [Full Text] [Related]
24. Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
McMahon LJ; Jones SE; Durie BG; Salmon SE
Cancer Lett; 1975 Nov; 1(2):97-102. PubMed ID: 65213
[TBL] [Abstract][Full Text] [Related]
25. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
[TBL] [Abstract][Full Text] [Related]
26. [Chemotherapy of bronchial carcinomas (author's transl)].
Karrer K; Pridun N; Zwintz E
Z Erkr Atmungsorgane; 1975 Feb; 142(2):149-63. PubMed ID: 818828
[TBL] [Abstract][Full Text] [Related]
27. [Combination chemotherapy of small cell bronchial carcinomas. Complete remissions].
Mannes P; Derriks R; Mannes R
Lille Med; 1978 May; 23(3):187-91. PubMed ID: 206794
[No Abstract] [Full Text] [Related]
28. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
Bonadonna G; Tancini G; Bajetta E
Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
[No Abstract] [Full Text] [Related]
29. [Prevention of recurrence of small-cell lung cancer by adjuvant polychemotherapy (author's transl)].
Karrer K; Denck H; Pridun N; Zwintz E
Wien Klin Wochenschr; 1982 Apr; 94(7):159-65. PubMed ID: 6285622
[TBL] [Abstract][Full Text] [Related]
30. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
31. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy in primary and metastatic intrathoracic cancer].
Mannes P; Derriks R; Moens R; Laurent C
Ann Med Interne (Paris); 1976 Jan; 127(1):25-34. PubMed ID: 1008360
[TBL] [Abstract][Full Text] [Related]
33. [Results of a sequential polychemotherapy (adriamycin, vincristine, cyclophosphamide, methotrexate) in small-cell and undifferentiated bronchial cancer].
Taytard A; Chomy P; Courty G; Gachie JP; Roquain J
Rev Fr Mal Respir; 1980; 8(3):225-32. PubMed ID: 6314444
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy in recurrent heat and neck cancer.
Simmonds WP
Otolaryngol Clin North Am; 1974 Feb; 7(1):205-15. PubMed ID: 4130287
[No Abstract] [Full Text] [Related]
35. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
[TBL] [Abstract][Full Text] [Related]
36. [Antineoplastic chemotherapy of head and neck tumors (author's transl)].
Weidauer H
HNO; 1981 Nov; 29(11):374-80. PubMed ID: 6171551
[TBL] [Abstract][Full Text] [Related]
37. Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.
Georgoulias V; Misset JL; Ribaud P; Machover D; De Vassal F; Dorval T; Musset M; Schwarzenberg L; Reizenstein P; Mathe G; Gaget H
Anticancer Res; 1983; 3(2):107-10. PubMed ID: 6189445
[TBL] [Abstract][Full Text] [Related]
38. [Chemotherapy of non-microcellular disseminated bronchial cancer (author's transl)].
Lamy P; Lamaze R; Weber B
Rev Fr Mal Respir; 1979 Dec; 7(7):742-5. PubMed ID: 95488
[TBL] [Abstract][Full Text] [Related]
39. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
[TBL] [Abstract][Full Text] [Related]
40. Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
Valdivieso M; Bodey GP; Benjamin RS; Barkley HT; Freeman MB; Ertel M; Smith TL; Mountain CF
Cancer Treat Rep; 1981; 65 Suppl 5():145-50. PubMed ID: 6809324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
